• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » How To Make Your Clinical Monitoring Efforts Matter

How To Make Your Clinical Monitoring Efforts Matter

February 9, 2021 By Sponsored Content

How should sponsors and sites define successful clinical monitoring today, and what can they do to ensure they achieve their goals?

By John Lehmann, Director of Business Development

Whether you’re performing it on-site or remotely, clinical monitoring comes with many challenges. In the past decade (and even the past year), monitoring has evolved.

How should sponsors and sites define successful monitoring today, and what can they do to ensure they achieve their goals? Here’s a closer look at what monitoring should accomplish and how to improve outcomes.

What Is Clinical Monitoring?

The FDA defines monitoring as the act of overseeing an investigation. The International Organization for Standardization elaborates further, explaining that the purpose is to ensure an investigation is “conducted, recorded, and reported in accordance with the clinical investigational plan (CIP), written procedures, the International Standard, and the applicable regulatory requirements.” (ISO 14155:2011(E) 3.29; ICH E6 1.38).

To break it down further, the primary goals of monitoring include:

  • Protecting the rights and wellbeing of study subjects
  • Ensuring data integrity
  • Ensuring the trial is conducted according to established plans and regulations
  • Identifying areas of non-compliance
  • Promoting high standards of quality
  • Identifying research misconduct or fraud

These are significant responsibilities, and they shouldn’t rest solely on one person. Clinical monitoring is a mindset everyone involved in research should adopt.

3 Steps To Improve Your Clinical Monitoring Efforts

1. Identify Quality Monitors

Clinical research associates (CRAs) or field monitors are the most well-known type of monitor. They may conduct site assessment visits, site initiation or training visits, interim monitoring visits, and/or close-out visits.

Although FDA regulations state that monitors should be qualified by training and experience, it does not specify any standard qualifications. Monitors often come from a variety of medical and scientific backgrounds, and many adopt their own processes and procedures.

Fortunately, the Code of Federal Regulations (21 CFR 812.43(d) offers guidance on what qualities to look for:

  • Regulatory knowledge
  • Clinical/scientific knowledge
  • Knowledge of the investigational plan
  • Knowledge of the device being studied
  • Knowledge of sponsor procedures

It’s important to document these qualifications and training. As we often say, if it wasn’t documented, it wasn’t done!

2. Develop A Monitoring Plan

A well-structured monitoring plan defines the expectations of monitors and helps improve compliance. The idea behind risk-based monitoring is to plan and prioritize monitoring activities based on the risks involved.

Here are a few questions to consider as you develop your plan:

  • What type of study is being conducted? (IDE? 510(k)?)
  • What are the risks?
  • How many sites and subjects will be involved?
  • How complex is the study?
  • What are the endpoints and measures? Are they quantitative or qualitative?
  • How much data is being collected?
  • How complex is the study population?
  • What is the expected rate of enrollment?
  • What is the experience level of the investigational sites(s)?
  • Where is the data being used?

Depending on your answers, you may determine you need more or less frequent monitoring visits. You may also decide your study is a good candidate for remote monitoring, on-site monitoring, or a hybrid approach that includes a mix of both.

3. Perform Monitoring Training

Even after you’ve hired well-qualified monitors, enrolling them in a standard clinical research training program ensures they have the foundational knowledge they need to apply the regulations and think critically. It also helps establish consistent processes.

Here are a few of the most important subjects to cover in your training for monitors:

  • Ensuring informed consent. Monitors review all informed consent documents, including obtaining electronic informed consent (e-consent.) They need to ensure all subjects gave proper informed consent to participate in the clinical trial and that this was documented correctly.
  • Assessing data integrity. Monitors review medical records and compare them to the records submitted to the sponsor. They need to be trained to spot any discrepancies and submit a data query to resolve them. Monitors should also clarify questionable source documentation to ensure the data being submitted accurately reflects the appropriate source and the clinical condition of the study participant.
  • Assessing protocol compliance. Failure to comply with study protocol is one of the most frequent violations cited in FDA Warning Letters. This is why it’s imperative that monitors ensure sites adhere to all established protocol. If they notice discrepancies, they should discuss a corrective action plan.
  • Reviewing essential documents. Monitors also review essential documentation, including IRB correspondence, sponsor correspondence, lab certifications, CVs, and training records. As they review these documents, they should refer to the FDA Guidance for Industry ICH GCP E6, Sections 8.2-8.4 or the ISO 14155:2011(E) Annex E.
  • Assessing overall site capabilities. Monitors periodically tour research sites, including procedure rooms, device storage areas, research documentation storage, and patient follow-up areas. They also interview study personnel and need to know how to spot any areas of concern. For instance, do research coordinators have enough time to complete their tasks? Are they properly trained? Monitors should feel confident making recommendations to sites to enhance any areas that need improvement.
  • Assessing device accountability. Monitors conduct investigational product accountability, comparing what was sent from the sponsor to what was used or returned and what is in stock at the site. They should ensure only appropriate study personnel had access to the investigational product and devices were only used in subjects who gave informed consent.

The Benefits Of Hiring A Monitoring CRO

Effective monitoring is vital to protecting patients, ensuring data integrity, and ultimately obtaining approval for your device. Hiring quality monitors, training them, and holding them accountable to hold your sites accountable takes time and effort, but it’s essential if you want your study to succeed.

Sponsored content by IMARC

Filed Under: Sponsored Content Tagged With: IMARC

In case you missed it

  • Once-a-week insulin dosing shows promise in studies
  • Abbott’s MitraClip doesn’t hinder oxygen levels, study shows
  • AdvaMed launches medtech podcast
  • Oncocyte acquires Chronix Biomedical
  • FDA nixes EUA for Lilly’s bamlanivimab
  • Seigla Medical gains CE mark for guide catheter extension
  • Contego Medical carotid stent wins CE mark approval
  • Pump problem prompts another Alaris recall
  • Virta Health raises $133M Series E for diabetes reversal tech
  • Canon Medical cardiac CT wins FDA clearance
  • MedTech 100 roundup: Industry skies to all-time high
  • DTW Podcast: How is Zimmer Biomet waging the ortho data war? Do medical devices carry physics-based biases?
  • Another BD Alaris infusion pump recall is Class I
  • 9 medical devices you should keep an eye out for in 2021
  • A quick history of the tech behind J&J, AstraZeneca’s COVID-19 vaccines
  • FDA finalizes rule to scale back how it regulates medtech software
  • Qorvo wins FDA nod for test that uses acoustic waves to detect COVID-19 antigens

RSS From Medical Design & Outsourcing

  • In situ cure technology molds next-gen medical implants
    Innovation in silicone technology has moved beyond defining specific material characteristics and into offering implantable devices that cure and form into shape inside the human body. Benny David, NuSil from Avantor Medical device manufacturers have long relied on highly purified silicone elastomers to fabricate components or entire devices for implantation. Now, recent innovations offer manufacturers… […]
  • How to prevent and troubleshoot short shots in medtech molding
    Deliberate processes to identify and remediate the problem can yield high-quality products and keep patients safe. Shane Vandekerkhof, RJG Short shots are among the most common and visually obvious quality issues most molders face, but they can cause fatal flaws in medical devices. Imagine if a luer lock connector was short. You run the risk… […]
  • AdvaMed launches medtech podcast
    AdvaMed today announced the launch of a new podcast, MedTech POV. AdvaMed president and CEO Scott Whitaker hosts the podcast, which covers the intersection of medtech and policy from a variety of perspectives. Each episode will feature discussions with medtech and healthcare policy leaders on issues that are driving the day — from business to… […]
  • This wearable could signal cytokine storms
    Researchers at the University of Texas at Dallas have developed a sweat sensor that could detect cytokine storms in patients suspected of having COVID-19 and other illnesses. Early on in the pandemic, doctors found that patients who developed a surge of pro-inflammatory immune proteins, called “cytokine storms,” were more often the sickest and at the… […]
  • How to evaluate laser performance for medical device manufacturing
    Laser processing provides automation and efficiencies that help meet FDA regulations and produce superior medical device components. David Locke, ACSYS Lasertechnik US Laser systems have become essential to the production of better-designed medical devices. The precision, repeatability and scale needed to manufacture next-generation medical products rely heavily on the advantages that lasers bring to contract… […]
  • EPA delayed notifying residents of ethylene oxide emissions
    The EPA delayed notifying neighbors of an Illinois medical device sterilization plant of ethylene oxide (EtO) emissions the agency measured in 2018, according to an inspector general’s report released yesterday. The report also says that “leadership” in the agency’s Office of Air and Radiation also failed to conduct public meetings with residents either near the… […]
  • 9 medical devices you should keep an eye out for in 2021
    The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek… […]
  • Greenlight Guru to provide QMS to NIH diagnostics program
    NIH has chosen Greenlight Guru to provide quality management software for its COVID-19 rapid diagnostics program. The agency launched the Rapid Acceleration of Diagnostics (RADx) program in March 2020 to speed the development, commercialization and implementation COVID-19 testing technologies. As the only QMS provider currently available to all projects in the RADx program, Greenlight Guru… […]
  • MicroCare names CFO
    MicroCare (New Britain, Conn.) has announced the appointment of John Stardellis as the company’s new chief financial officer (CFO). Stardellis joins MicroCare with more than 20 years’ experience in a variety of finance, policy and operational leadership roles. Most recently, he served as CFO at i-Health, a division of DSM Nutritional Products. “John’s track record with… […]
  • Mayo Clinic helps launch two new companies for improved diagnostics
    Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform (RDMP) is designed to connect data with new AI algorithms and augment human decision-making within existing clinical workflows, according to a news release. Get the full story… […]
  • Intertek gains FDA nod for premarket device testing
    Intertek has won accreditation under an FDA pilot program for testing laboratories, the company said this week. The accreditation authorizes Intertek’s 12 “medical centers of excellence” to perform premarket testing of devices for the U.S. market. The Accreditation Scheme for Conformity Assessment pilot program is a voluntary program developed to provide increased confidence in testing… […]

Primary Sidebar

DeviceTalks by MassDevice · How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS